Split History
ETFs Holding PRTK »    PRTK Historical Stock Prices »
Video: What is a Stock Split?

If the video does not load after a few moments, Upgrade to the Latest Flash Player.
Paratek Pharmaceuticals is a commercial-stage biopharmaceutical company focused on the development and commercialization of therapies for diseases or other public health threats for civilian, government and military use. Co.'s U.S. Food and Drug Administration approved commercial product, NUZYRA®, is a once-daily oral and intravenous antibiotic for the treatment of adult patients with community-acquired bacterial pneumonia, and acute skin and skin structure infections caused by susceptible pathogens. SEYSARA®, is being marketed by Almirall, LLC in the U.S. as a new once-daily oral therapy for the treatment of moderate to severe acne vulgaris. According to our PRTK split history records, Paratek Pharmaceuticals has had 1 split.
PRTK split history picture
Paratek Pharmaceuticals (PRTK) has 1 split in our PRTK split history database. The split for PRTK took place on October 31, 2014. This was a 1 for 12 reverse split, meaning for each 12 shares of PRTK owned pre-split, the shareholder now owned 1 share. For example, a 1000 share position pre-split, became a 83.3333333333333 share position following the split.

When a company such as Paratek Pharmaceuticals conducts a reverse share split, it is usually because shares have fallen to a lower per-share pricepoint than the company would like. This can be important because, for example, certain types of mutual funds might have a limit governing which stocks they may buy, based upon per-share price. The $5 and $10 pricepoints tend to be important in this regard. Stock exchanges also tend to look at per-share price, setting a lower limit for listing eligibility. So when a company does a reverse split, it is looking mathematically at the market capitalization before and after the reverse split takes place, and concluding that if the market capitilization remains stable, the reduced share count should result in a higher price per share.

Looking at the PRTK split history from start to finish, an original position size of 1000 shares would have turned into 83.3333333333333 today. Below, we examine the compound annual growth rate — CAGR for short — of an investment into Paratek Pharmaceuticals shares, starting with a $10,000 purchase of PRTK, presented on a split-history-adjusted basis factoring in the complete PRTK split history. PRTK split adjusted history picture

Growth of $10,000.00
With Dividends Reinvested

Start date: 09/28/2012
End date: 09/26/2022
Start price/share: $63.72
End price/share: $2.23
Starting shares: 156.94
Ending shares: 522.16
Dividends reinvested/share: $31.97
Total return: -88.36%
Average Annual Total Return: -19.35%
Starting investment: $10,000.00
Ending investment: $1,164.24
Years: 10.00
Growth of $10,000.00
Without Dividends Reinvested

Start date: 09/28/2012
End date: 09/26/2022
Start price/share: $63.72
End price/share: $2.23
Dividends collected/share: $31.97
Total return: -46.32%
Average Annual Total Return: -6.03%
Starting investment: $10,000.00
Ending investment: $5,368.99
Years: 10.00
Date Ratio
10/31/20141 for 12
PRTK is categorized under the Healthcare sector; below are some other companies in the same sector that also have a history of stock splits:

PRXL Split History
PSTI Split History
PTIE Split History
PTN Split History
PTX Split History
PULM Split History
PVCT Split History
Q Split History
QGEN Split History
QLTI Split History

Also explore: PRTK shares outstanding history

Email EnvelopeFree PRTK Email Alerts:
Get Dividend Alerts
Get SEC Filing Alerts

Avenue Therapeutics, Inc. (ATXI)
Annaly Capital Management, Inc. (NLY)
CohBar, Inc. (CWBR)
TOP Ships Inc. (TOPS)
Sonnet BioTherapeutics Holdings, Inc. (SONN)
Nabriva Therapeutics plc (NBRV)
NeuroBo Pharmaceuticals, Inc. (NRBO)
First Wave BioPharma, Inc. (FWBI)
Palatin Technologies, Inc. (PTIN)
TD Holdings, Inc. (GLG )
More latest stock splits »
Latest mega mergers »
Latest stock buybacks »

PRTK Insider Buying

PRTK Split History | www.SplitHistory.com | Copyright © 2013 - 2022, All Rights Reserved

Nothing in www.SplitHistory.com is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. Split history database is not guaranteed to be complete or free of errors. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Service. Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.